Back to resultsEvaluation of the Use of the Atalante System in Patients Presenting a Non-traumatic Hemiplegia in Acute-subacute Phase (15 Days to 6 Months). (SPIRIT)
Primary Purpose
Stroke, Stroke, Acute, Stroke, Subacute
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Use of the Atalante exoskeleton
Sponsored by
About this trial
This is an interventional other trial for Stroke focused on measuring Stroke, Acute Stroke, Subacute Stroke, Robotics, Physiotherapy, Rehabilitation, Powered exoskeleton, Walking, Exercises, Ambulation
Eligibility Criteria
Inclusion Criteria:
- Non-walking patient (FAC score at 0 or 1) with non-traumatic vascular hemiplegia in acute subacute phase (15 days to 3 months) hospitalized in rehabilitation center,
- Patient with ischemic stroke of which etiological evaluation is complete,
- Adult patient ≥18 years old and <75 years old,
- Patient able to verticalize on a daily basis and having a stabilized blood pressure,
- Patient with stable medical condition at the time of inclusion in the study (absence of infectious and cardiorespiratory events),
- Patient's height is at least 1m55,
Lengths of patient's lower limb are in the following intervals:
- Thigh (distance gluteus maximus - patella): 56.8 and 64.8 cm,
Distance between the ground and the joint space of the knee (to be measured while wearing the shoes the patient intends to wear with Atalante):
- 45.7-60.7 cm for patient with an ankle dorsiflexion ≥ 16°
- 45.7-57.7 cm for patient with an ankle dorsiflexion > 13° et < 16°
- 45.7-56.7 cm for patient with an ankle dorsiflexion > 10° et ≤ 13°
- 45.7-55.7 cm for patient with an ankle dorsiflexion ≥ 0° et ≤ 10°
- Intertrochanteric distance lower or equal to 46.0 cm when seated,
- Maximum weight: 90 kg,
- Patient able to read and write French and who have signed an informed consent form.
Exclusion Criteria:
Ranges of motion below:
- Hip: 90° flexion, 5° extension, 17° abduction, 10° adduction, 10° medial rotation, 20° lateral rotation
- Knee: 5° extension, 110° flexion
- Ankle: 0° dorsiflexion, 9° plantar flexion, 18° inversion and eversion
- Patient whose joint centers cannot be aligned Atalante's system,
- Severe spasticity (greater than 3 on the modified Ashworth scale) of the adductor muscles, hamstrings, quadriceps and triceps surae
- Pregnant or lactating women,
- Medical history of osteoporotic fracture and/or disease or treatment responsible for a secondary osteoporosis,
- Patient with a cardiac contraindication to physical exertion,
- Evolutive intercurrent disease: venous thrombosis, hypotension,
- Patient unable to deliver his/her consent,
- Patient under legal protection,
- Patient participating at the same time in another study.
Sites / Locations
- Centre Jacques Calvé - Fondation Hopale
- Centre mutualiste de Rééducation et de Réadaptation de Kerpape
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Non-traumatic hemiplegia in post stroke acute subacute phase
Arm Description
Outcomes
Primary Outcome Measures
Evaluate the use of the Atalante system in patients with non-traumatic acute-subacute hemiplegia over several sessions with a 10 meter Walk Test. This test will show the incidence of test success and emergence of adverse events.
Defined by the patient's ability to perform the 10mWT with the Atalante system.
Evaluate the use of the Atalante system in patients with non-traumatic acute-subacute hemiplegia over several sessions with a 10 meter Walk Test. This test will show the incidence of test success and emergence of adverse events.
Defined by the patient's ability to perform the 10mWT with the Atalante system
Evaluate the use of the Atalante system in patients with non-traumatic acute-subacute hemiplegia over several sessions with a 10 meter Walk Test. This test will show the incidence of test success and emergence of adverse events.
Defined by the patient's ability to perform the 10mWT with the Atalante system
Evaluate the use of the Atalante system in patients with non-traumatic acute-subacute hemiplegia over several sessions with a 10 meter Walk Test. This test will show the incidence of test success and emergence of adverse events.
Defined by the patient's ability to perform the 10mWT with the Atalante system
Evaluate the use of the Atalante system in patients with non-traumatic acute-subacute hemiplegia over several sessions with a 10 meter Walk Test. This test will show the incidence of test success and emergence of adverse events.
Defined by the patient's ability to perform the 10mWT with the Atalante system
Secondary Outcome Measures
Evaluate the patient's ambulatory ability without the Atalante exoskeleton with the Functional Ambulation Classification.
Evaluation of the walk performance with the FAC classification.
0: Nonfunctional ambulation
Ambulator-Dependent for Physical Assistance Level II
Ambulator-Dependent for Physical Assistance Level I
Ambulator-Dependent for Supervision
Ambulator-Independent Level Surfaces only
Ambulator-Independent
Evaluate the settings of the walking parameters of the exoskeleton deemed most efficient by the patient (step length, cadence)
During sessions 2 to 5, the physiotherapist will vary the step length and cadence of the exoskeleton's walk.
Each parameter will be tested over a distance of 10 meters. Perceived exertion and perceived safety will be assessed by the patient using a Likert Scale. Physiotherapist satisfaction (evaluated on a Likert Scale) will be assessed at the end of the test.
Likert scale :
"strongly disagree"
"disagree"
"neither agree or disagree",
"agree",
"strongly agree",
Evaluate the assistive control settings
The test is performed in EXERCISE mode. Atalante accompanies the movements of the upper body while stabilizing the entire system.
As a result of this transfer, a quasi-static step is triggered. This step is more or less assisted: the effort provided by the patient is modulated by the physiotherapist (100% of assistance equals 0% effort of the patient, Atalante performs the movement instead of the patient). The patient takes a step forward and at the end of the step, Atalante returns to the EXERCISE mode and is ready to connect a second quasi-static step by soliciting the opposite leg. The patient has to transfer his/her weight for 2 seconds on the opposite leg to trigger the step.
Values of tested assistance levels assessed will be collected as perceived exertion, perceived safety and physiotherapist satisfaction (evaluated on a Likert Scale).
Likert scale :
"strongly disagree"
"disagree"
"neither agree or disagree",
"agree",
"strongly agree",
Evaluate the assistive control settings
The test of dynamic assistance is performed in WALK mode. The patient starts by leaning the right side (or left side). Then, as soon as the user presses WALK button, a first step is triggered by the exoskeleton. Next steps are more or less assisted depending on the level of assistance chosen by the physiotherapist (100% of assistance equals 0% effort of the patient, Atalante performs the movement instead of the patient). The patient must initiate each step by pushing on the opposite leg and making a pelvic rotation towards the forward foot.
Values of tested assistance levels assessed will be collected as perceived exertion, perceived safety and physiotherapist satisfaction (evaluated on a Likert Scale).
Likert scale :
"strongly disagree"
"disagree"
"neither agree or disagree",
"agree",
"strongly agree",
Evaluate the patient's ability to perform weight transfer on the hemiplegic side or the healthy side
Success/ Failure to the exercise: transfer of weight to the right or left side until the sound signal is triggered
Evaluate the patient's ability to perform a semi-squat
Success/ Failure to the exercise: perform a semi-squat
Evaluate the patient's ability to perform functional tests with the Atalante exoskeleton with a Time Up and Go test
Success/ Failure to the TUG test (Time Up and Go test)
Evaluate the level of assistance needed by the patient from the healthcare staff to perform tests
The therapist will record the level(s) of assistance needed to perform each test and detail the moment on which assistance was needed during the test. The level of assistance will be determined with the number of times the therapist will have helped the patient during the tests, as well as the type of assistance he/she will have provided.
The physiotherapist will select on a scale the level of assistance he/she provided during the test:. None (0% of assistance) - Minimal (0-25% assistance) - Moderate (25-50% assistance) - High (50-75% assistance) - Maximum (75-100% assistance).
Evaluate the time needed for the patient to don and doff
Collection of data regarding the time needed for patient to donning and doff
Evaluate the patient's physical and cognitive conditions using the Berg Balance Scale
The Berg Balance Scale (BBS) is a 14-item objective measure that assesses static balance and risk of fall in adult. In this 14-item scale, patient must maintain positions and complete moving tasks of varying difficulty. In most items, patient must maintain a given position for a specified time. Patient receives a score from 0-4 on his/her ability to meet these balance dimensions:
0-20 on the BBS represents balance impairment;
21-40 on the BBS represents acceptable balance;
41-56 on the BBS represents good balance. This measure will be performed during sessions 0 and 10 in order to assess a potential variation.
Evaluate the patient's physical and cognitive conditions
Evaluation of the level of aphasia by the aphasia severity rating scale from the Boston Diagnostic Aphasia Examination.
The degree of aphasia will be evaluated using the aphasia severity rating scale from the Boston Diagnostic Aphasia Examination (BDAE). BDAE is designed to diagnose aphasia and related disorders. This test evaluates the various conceptual modalities (auditory, visual and gestural), the processing functions (comprehension, analysis, problem solving) and the response modalities (writing, articulation and manipulation).
The aphasia severity rating scale from the BDAE will be done at baseline in order to describe the population participating in the study.
Evaluate the safety of the exoskeleton by collecting the incidence of points of contact, induced pain, edema, and other potential adverse events
Collection of medical events relating to cutaneous, algological and infectious morbidity
Evaluate the level of effort perceived during each test by using the Borg scale
Rating of perceived exertion (RPE) will be used to assess the effort perceived by patient at each session. RPE is a widely used and reliable indicator to monitor and guide exercise intensity. The scale allows individuals to subjectively rate their level of exertion during exercise or exercise testing.
The revised category-ratio scale (0 to 10 scale) is used:
0 Null
1 Very easy
2 Somewhat easy-
3 Moderate
4 Somewhat hard
5 Hard
6
7 Very hard
8
9
10 Very, very hard
Evaluate the level of security perceived during each test by using a 5-level Likert scale
Perceived safety during tests will be assessed by each patient using a 5-point Likert scale format ranging from 5)"strongly agree", 4)"agree", 3)"neither agree or disagree", 2)"disagree" and 1)"strongly disagree".
The range of Likert scale captures the intensity of his/her feeling for a given item
Evaluate the level of anxiety of patient related to the use of the exoskeleton
Collection of the patient's level of anxiety assessed by a 5-level Likert scale:
"strongly disagree"
"disagree"
"neither agree or disagree",
"agree",
"strongly agree",
Evaluate the emergence of musculoskeletal disorders in the therapist
Evaluation of musculoskeletal disorders developed by healthcare professionals in the use of exoskeleton with a Nordic style questionnaire.
The Nordic Musculoskeletal Questionnaire (NMQ) is a 2-section questionnaire. The aim was to develop and test a standardized questionnaire methodology allowing comparison of low back, neck, shoulder and general complaints.
The NMQ can be used as a questionnaire or as a structured interview.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04187209
Brief Title
Evaluation of the Use of the Atalante System in Patients Presenting a Non-traumatic Hemiplegia in Acute-subacute Phase (15 Days to 6 Months).
Acronym
SPIRIT
Official Title
Evaluation of the Use of the Atalante System in Patients Presenting a Non-traumatic Hemiplegia in Acute-subacute Phase (15 Days to 6 Months).
Study Type
Interventional
2. Study Status
Record Verification Date
November 2022
Overall Recruitment Status
Completed
Study Start Date
September 11, 2019 (Actual)
Primary Completion Date
January 13, 2021 (Actual)
Study Completion Date
January 13, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Wandercraft
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The SPIRIT study is interventional, national, prospective, open, bicentric each patient being his/her own control.
It is conducted to assess the safety and performance of the Atalante exoskeleton system in patients presenting a non-traumatic acute-subacute hemiplegia. The primary endpoint is defined by the patient's ability to perform the 10 MWT with the Atalante system.
The study will include 16 patients and takes place in two french rehabilitation centers.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke, Stroke, Acute, Stroke, Subacute, Robotics
Keywords
Stroke, Acute Stroke, Subacute Stroke, Robotics, Physiotherapy, Rehabilitation, Powered exoskeleton, Walking, Exercises, Ambulation
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
12 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Non-traumatic hemiplegia in post stroke acute subacute phase
Arm Type
Other
Intervention Type
Device
Intervention Name(s)
Use of the Atalante exoskeleton
Intervention Description
A session includes a stand-up, walks over a distance of 10 meters, exercises with or without the assistance of the exoskeleton, U-turns and a sitting.
Primary Outcome Measure Information:
Title
Evaluate the use of the Atalante system in patients with non-traumatic acute-subacute hemiplegia over several sessions with a 10 meter Walk Test. This test will show the incidence of test success and emergence of adverse events.
Description
Defined by the patient's ability to perform the 10mWT with the Atalante system.
Time Frame
At study mid-term, 6 days in average
Title
Evaluate the use of the Atalante system in patients with non-traumatic acute-subacute hemiplegia over several sessions with a 10 meter Walk Test. This test will show the incidence of test success and emergence of adverse events.
Description
Defined by the patient's ability to perform the 10mWT with the Atalante system
Time Frame
At study mid-term, 7 days in average
Title
Evaluate the use of the Atalante system in patients with non-traumatic acute-subacute hemiplegia over several sessions with a 10 meter Walk Test. This test will show the incidence of test success and emergence of adverse events.
Description
Defined by the patient's ability to perform the 10mWT with the Atalante system
Time Frame
At study mid-term, 8 days in average
Title
Evaluate the use of the Atalante system in patients with non-traumatic acute-subacute hemiplegia over several sessions with a 10 meter Walk Test. This test will show the incidence of test success and emergence of adverse events.
Description
Defined by the patient's ability to perform the 10mWT with the Atalante system
Time Frame
At study completion, 9 days in average
Title
Evaluate the use of the Atalante system in patients with non-traumatic acute-subacute hemiplegia over several sessions with a 10 meter Walk Test. This test will show the incidence of test success and emergence of adverse events.
Description
Defined by the patient's ability to perform the 10mWT with the Atalante system
Time Frame
At study completion, 10 days in average
Secondary Outcome Measure Information:
Title
Evaluate the patient's ambulatory ability without the Atalante exoskeleton with the Functional Ambulation Classification.
Description
Evaluation of the walk performance with the FAC classification.
0: Nonfunctional ambulation
Ambulator-Dependent for Physical Assistance Level II
Ambulator-Dependent for Physical Assistance Level I
Ambulator-Dependent for Supervision
Ambulator-Independent Level Surfaces only
Ambulator-Independent
Time Frame
At baseline, day 0 and at study completion, up to 10 days
Title
Evaluate the settings of the walking parameters of the exoskeleton deemed most efficient by the patient (step length, cadence)
Description
During sessions 2 to 5, the physiotherapist will vary the step length and cadence of the exoskeleton's walk.
Each parameter will be tested over a distance of 10 meters. Perceived exertion and perceived safety will be assessed by the patient using a Likert Scale. Physiotherapist satisfaction (evaluated on a Likert Scale) will be assessed at the end of the test.
Likert scale :
"strongly disagree"
"disagree"
"neither agree or disagree",
"agree",
"strongly agree",
Time Frame
At study start, day 2 until study mid term, day 5
Title
Evaluate the assistive control settings
Description
The test is performed in EXERCISE mode. Atalante accompanies the movements of the upper body while stabilizing the entire system.
As a result of this transfer, a quasi-static step is triggered. This step is more or less assisted: the effort provided by the patient is modulated by the physiotherapist (100% of assistance equals 0% effort of the patient, Atalante performs the movement instead of the patient). The patient takes a step forward and at the end of the step, Atalante returns to the EXERCISE mode and is ready to connect a second quasi-static step by soliciting the opposite leg. The patient has to transfer his/her weight for 2 seconds on the opposite leg to trigger the step.
Values of tested assistance levels assessed will be collected as perceived exertion, perceived safety and physiotherapist satisfaction (evaluated on a Likert Scale).
Likert scale :
"strongly disagree"
"disagree"
"neither agree or disagree",
"agree",
"strongly agree",
Time Frame
At study start, day 2
Title
Evaluate the assistive control settings
Description
The test of dynamic assistance is performed in WALK mode. The patient starts by leaning the right side (or left side). Then, as soon as the user presses WALK button, a first step is triggered by the exoskeleton. Next steps are more or less assisted depending on the level of assistance chosen by the physiotherapist (100% of assistance equals 0% effort of the patient, Atalante performs the movement instead of the patient). The patient must initiate each step by pushing on the opposite leg and making a pelvic rotation towards the forward foot.
Values of tested assistance levels assessed will be collected as perceived exertion, perceived safety and physiotherapist satisfaction (evaluated on a Likert Scale).
Likert scale :
"strongly disagree"
"disagree"
"neither agree or disagree",
"agree",
"strongly agree",
Time Frame
Study mid term, day 4
Title
Evaluate the patient's ability to perform weight transfer on the hemiplegic side or the healthy side
Description
Success/ Failure to the exercise: transfer of weight to the right or left side until the sound signal is triggered
Time Frame
At study start, day 2 until study mid term, day 4
Title
Evaluate the patient's ability to perform a semi-squat
Description
Success/ Failure to the exercise: perform a semi-squat
Time Frame
At study start, day 3 until study mid term, day 5
Title
Evaluate the patient's ability to perform functional tests with the Atalante exoskeleton with a Time Up and Go test
Description
Success/ Failure to the TUG test (Time Up and Go test)
Time Frame
At study mid-term, day 7 until study completion, day 9
Title
Evaluate the level of assistance needed by the patient from the healthcare staff to perform tests
Description
The therapist will record the level(s) of assistance needed to perform each test and detail the moment on which assistance was needed during the test. The level of assistance will be determined with the number of times the therapist will have helped the patient during the tests, as well as the type of assistance he/she will have provided.
The physiotherapist will select on a scale the level of assistance he/she provided during the test:. None (0% of assistance) - Minimal (0-25% assistance) - Moderate (25-50% assistance) - High (50-75% assistance) - Maximum (75-100% assistance).
Time Frame
Throughout study completion, an average of 10 days
Title
Evaluate the time needed for the patient to don and doff
Description
Collection of data regarding the time needed for patient to donning and doff
Time Frame
At study completion, day 10
Title
Evaluate the patient's physical and cognitive conditions using the Berg Balance Scale
Description
The Berg Balance Scale (BBS) is a 14-item objective measure that assesses static balance and risk of fall in adult. In this 14-item scale, patient must maintain positions and complete moving tasks of varying difficulty. In most items, patient must maintain a given position for a specified time. Patient receives a score from 0-4 on his/her ability to meet these balance dimensions:
0-20 on the BBS represents balance impairment;
21-40 on the BBS represents acceptable balance;
41-56 on the BBS represents good balance. This measure will be performed during sessions 0 and 10 in order to assess a potential variation.
Time Frame
At baseline, day 0 and at study completion, up to 10 days
Title
Evaluate the patient's physical and cognitive conditions
Description
Evaluation of the level of aphasia by the aphasia severity rating scale from the Boston Diagnostic Aphasia Examination.
The degree of aphasia will be evaluated using the aphasia severity rating scale from the Boston Diagnostic Aphasia Examination (BDAE). BDAE is designed to diagnose aphasia and related disorders. This test evaluates the various conceptual modalities (auditory, visual and gestural), the processing functions (comprehension, analysis, problem solving) and the response modalities (writing, articulation and manipulation).
The aphasia severity rating scale from the BDAE will be done at baseline in order to describe the population participating in the study.
Time Frame
At baseline, day 0
Title
Evaluate the safety of the exoskeleton by collecting the incidence of points of contact, induced pain, edema, and other potential adverse events
Description
Collection of medical events relating to cutaneous, algological and infectious morbidity
Time Frame
Throughout study completion, an average of 10 days
Title
Evaluate the level of effort perceived during each test by using the Borg scale
Description
Rating of perceived exertion (RPE) will be used to assess the effort perceived by patient at each session. RPE is a widely used and reliable indicator to monitor and guide exercise intensity. The scale allows individuals to subjectively rate their level of exertion during exercise or exercise testing.
The revised category-ratio scale (0 to 10 scale) is used:
0 Null
1 Very easy
2 Somewhat easy-
3 Moderate
4 Somewhat hard
5 Hard
6
7 Very hard
8
9
10 Very, very hard
Time Frame
Throughout study completion, an average of 10 days
Title
Evaluate the level of security perceived during each test by using a 5-level Likert scale
Description
Perceived safety during tests will be assessed by each patient using a 5-point Likert scale format ranging from 5)"strongly agree", 4)"agree", 3)"neither agree or disagree", 2)"disagree" and 1)"strongly disagree".
The range of Likert scale captures the intensity of his/her feeling for a given item
Time Frame
Throughout study completion, an average of 10 days
Title
Evaluate the level of anxiety of patient related to the use of the exoskeleton
Description
Collection of the patient's level of anxiety assessed by a 5-level Likert scale:
"strongly disagree"
"disagree"
"neither agree or disagree",
"agree",
"strongly agree",
Time Frame
At study start, day 1 and at study completion, up to 10 days
Title
Evaluate the emergence of musculoskeletal disorders in the therapist
Description
Evaluation of musculoskeletal disorders developed by healthcare professionals in the use of exoskeleton with a Nordic style questionnaire.
The Nordic Musculoskeletal Questionnaire (NMQ) is a 2-section questionnaire. The aim was to develop and test a standardized questionnaire methodology allowing comparison of low back, neck, shoulder and general complaints.
The NMQ can be used as a questionnaire or as a structured interview.
Time Frame
At baseline, day 0 and at study completion, up to 10 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Non-walking patient (FAC score at 0 or 1) with non-traumatic vascular hemiplegia in acute subacute phase (15 days to 3 months) hospitalized in rehabilitation center,
Patient with ischemic stroke of which etiological evaluation is complete,
Adult patient ≥18 years old and <75 years old,
Patient able to verticalize on a daily basis and having a stabilized blood pressure,
Patient with stable medical condition at the time of inclusion in the study (absence of infectious and cardiorespiratory events),
Patient's height is at least 1m55,
Lengths of patient's lower limb are in the following intervals:
Thigh (distance gluteus maximus - patella): 56.8 and 64.8 cm,
Distance between the ground and the joint space of the knee (to be measured while wearing the shoes the patient intends to wear with Atalante):
45.7-60.7 cm for patient with an ankle dorsiflexion ≥ 16°
45.7-57.7 cm for patient with an ankle dorsiflexion > 13° et < 16°
45.7-56.7 cm for patient with an ankle dorsiflexion > 10° et ≤ 13°
45.7-55.7 cm for patient with an ankle dorsiflexion ≥ 0° et ≤ 10°
Intertrochanteric distance lower or equal to 46.0 cm when seated,
Maximum weight: 90 kg,
Patient able to read and write French and who have signed an informed consent form.
Exclusion Criteria:
Ranges of motion below:
Hip: 90° flexion, 5° extension, 17° abduction, 10° adduction, 10° medial rotation, 20° lateral rotation
Knee: 5° extension, 110° flexion
Ankle: 0° dorsiflexion, 9° plantar flexion, 18° inversion and eversion
Patient whose joint centers cannot be aligned Atalante's system,
Severe spasticity (greater than 3 on the modified Ashworth scale) of the adductor muscles, hamstrings, quadriceps and triceps surae
Pregnant or lactating women,
Medical history of osteoporotic fracture and/or disease or treatment responsible for a secondary osteoporosis,
Patient with a cardiac contraindication to physical exertion,
Evolutive intercurrent disease: venous thrombosis, hypotension,
Patient unable to deliver his/her consent,
Patient under legal protection,
Patient participating at the same time in another study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jacques Kerdraon, Dr
Organizational Affiliation
Centre mutualiste de Rééducation et de Réadaptation de Kerpape
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jean-Gabriel Prévinaire, Dr
Organizational Affiliation
Centre Jacques Calvé - Fondation Hopale de Berck-sur-Mer
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre Jacques Calvé - Fondation Hopale
City
Berck
ZIP/Postal Code
62600
Country
France
Facility Name
Centre mutualiste de Rééducation et de Réadaptation de Kerpape
City
Ploemeur
ZIP/Postal Code
56270
Country
France
12. IPD Sharing Statement
Learn more about this trial
Evaluation of the Use of the Atalante System in Patients Presenting a Non-traumatic Hemiplegia in Acute-subacute Phase (15 Days to 6 Months).
We'll reach out to this number within 24 hrs